Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.

Dombernowsky, P

Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. [electronic resource] - Cancer chemotherapy reports Feb 1972 - 71-82 p. digital

Publication Type: Journal Article

0069-0112


Adult
Aged
Animals
Antineoplastic Agents--therapeutic use
Female
Glycosides--therapeutic use
Haplorhini
Hodgkin Disease--drug therapy
Humans
Immunosuppression Therapy
Lactones--therapeutic use
Lymphoma--drug therapy
Male
Mice
Middle Aged
Neoplasms--drug therapy
Neoplasms, Experimental--drug therapy
Phytotherapy
Plants, Medicinal
Plants, Toxic
Podophyllin--toxicity
Podophyllum--therapeutic use
Rats
Thiophenes--therapeutic use